NACDS Urges DIR Fee Reform in Statement to House Ways and Means Committee Details opportunities to reduce patients’ out-of-pocket drug costs and to lower overall healthcare spending through DIR fee reform; Describes public’s trust of pharmacies’ cost-saving proposals

2019-02-12T17:07:13+00:00Feb-12-19|Categories: Press Release|Tags: , , , , |

NACDS today submitted a statement to the U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.”

NACDS, NCPA Thank Patient, Consumer Groups for Taking Important Stance on DIR Fee Reform Groups emphasize DIR fee reform’s power to reduce out-of-pocket drug costs and to reduce overall healthcare costs as a result of medication adherence and better health

2019-02-12T17:08:10+00:00Feb-12-19|Categories: Press Release|Tags: , , , , |

NACDS and the National Community Pharmacists Association (NCPA) today lauded 24 patient and consumer groups for advocating for pharmacy direct and indirect remuneration (DIR) fee reform.

NACDS, NCPA Praise Senate Action to Reduce Patient Drug Costs Bipartisan Senate letter to HHS Secretary urges swift action on pharmacy DIR fee reform to lower out-of-pocket drug costs for patients and to stop unworkable practices that are unfair to pharmacies

2019-02-12T17:08:57+00:00Feb-05-19|Categories: Press Release|Tags: , , , , |

NACDS and the National Community Pharmacists Association (NCPA) today praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar.

NACDS Demonstrates Need for DIR Fee Reform in Comments to CMS Supports agency proposal to reduce patients’ out-of-pocket drug costs, reduce overall healthcare costs, improve patient health, and address drastically unfair reimbursement to pharmacies

2019-01-25T11:49:12+00:00Jan-25-19|Categories: Press Release|Tags: , , , |

Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented

Pharmacy Groups Praise CMS’ Rejection of Below-Cost Medicaid Dispensing Fees in Washington State CMS’ decision is vital for pharmacy patient care in Washington State and across the nation

2018-09-11T18:44:57+00:00Sep-11-18|Categories: Press Release|Tags: , , , |

NACDS, WSPA, and NCPA applaud action by the federal Centers for Medicare & Medicaid Services (CMS) to reject Washington State’s below-cost and lowest-in-the-nation Medicaid pharmacy dispensing fees.

NACDS Comments to CMS on Medicare Prescription Drug Program Urges Medicare Part D policies related to DIR fee fairness, opioid abuse prevention, prescription drug affordability, and patients’ pharmacy access

2018-01-17T09:58:38+00:00Jan-17-18|Categories: Press Release|Tags: , |

NACDS expressed support for, and provided further input, on CMS’ proposed rule, which involves issues including direct and indirect remuneration fees; e-prescribing; medication therapy management; opioid abuse; and fostering pharmacy access.

Load More Posts